Stocktoria

Vera Therapeutics, Inc. VERA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-05-14

Vera Therapeutics, Inc. statistics & valuation

Market cap$2.4B
P / B4.0×
Return on equity-49.6%
Net cash$279.9M
Enterprise value USD$2.1B
Earnings yield EBIT/EV-14.8%
Return on capital-46.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-46.90% -115.80% -94.40% -26.40% -49.60% 202020212022202320242025
Shares outstanding
13.4M 26.6M 42.7M 55.3M 64.2M 202020212022202320242025
Net debt ($)
-$53.7M -$74.8M -$18.6M $4.2M -$42.0M -$279.9M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-97.90% -38.90% -67.80% -54.70% -23.20% -40.80% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
0.07× 0.32× 0.49× 0.09× 0.12× 202020212022202320242025
EPS ($)
-$2.43 -$3.35 -$2.25 -$2.75 -$4.66 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-40.8%-23.2%-54.7%-67.8%-38.9%-97.9%
Return on equity-49.6%-26.4%-94.4%-115.8%-46.9%59.8%
Debt / equity0.12×0.09×0.49×0.32×0.07×-0.00×
Current ratio13.6425.677.714.9110.7322.55

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.